Anandamide is also a lipid mediator that functions as an endogenous ligand (a protein that binds to a recptor) by attaching itself to the body’s CB1 receptors, the primary molecular target that’s responsible for the pharmacological effects of THC. Anandamide was discovered in the early ‘90s by Dr. Raphael Mechoulam, who was known for his groundbreaking research and discovery of delta-9-THC while trying to figure out why our bodies contained cannabinoid receptors that are capable of binding with external cannabinoids such as CBD and THC.
Yesterday, Colombian President Gustavo Petro appeared before the UN Commission on Narcotic Drugs, where he…
Before New Constellations started turning heads with dreamy synth-pop and soft-focus heat, Harlee Case was…
In High Times’ new documentary on Rove, one of cannabis culture’s most enduring rituals gets…
The best weed ads don’t feel like ads anymore. They feel like content built to…
“Do you know why I stopped you this evening?” “No sir, I was going the…
Virginia lawmakers have sent a marijuana resentencing bill to Gov. Abigail Spanberger, opening a path…